Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Factors associated with colon cancer screening: the role of patient factors and physician counseling.

Wee CC, McCarthy EP, Phillips RS.

Prev Med. 2005 Jul;41(1):23-9. Epub 2004 Dec 29.

PMID:
15916989
2.

Colorectal carcinoma screening among Hispanics and non-Hispanic whites in a rural setting.

Thompson B, Coronado G, Neuhouser M, Chen L.

Cancer. 2005 Jun 15;103(12):2491-8.

3.

A national survey of primary care physicians' methods for screening for fecal occult blood.

Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R, Smith RA, Ransohoff DF.

Ann Intern Med. 2005 Jan 18;142(2):86-94.

PMID:
15657156
4.

Colorectal cancer screening among men and women in the United States.

Peterson NB, Murff HJ, Ness RM, Dittus RS.

J Womens Health (Larchmt). 2007 Jan-Feb;16(1):57-65.

PMID:
17324097
5.

Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.

Baig N, Myers RE, Turner BJ, Grana J, Rothermel T, Schlackman N, Weinberg DS.

Am J Gastroenterol. 2003 Sep;98(9):2078-81.

PMID:
14499791
6.

Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.

Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, Fracchia M, Gasperoni S, Malfitana G, Recchia S, Risio M, Rizzetto M, Saracco G, Spandre M, Turco D, Turco P, Zappa M; SCORE2 Working Group-Italy.

J Natl Cancer Inst. 2005 Mar 2;97(5):347-57.

PMID:
15741571
7.

Ethnicity/race, use of pharmacotherapy, scope of physician-ordered cholesterol screening, and provision of diet/nutrition or exercise counseling during US office-based visits by patients with hyperlipidemia.

Willson MN, Neumiller JJ, Sclar DA, Robison LM, Skaer TL.

Am J Cardiovasc Drugs. 2010;10(2):105-8. doi: 10.2165/11532820-000000000-00000.

PMID:
20334447
8.

Physicians' recommendations for colon cancer screening in women. Too much of a good thing?

Richards C, Klabunde C, O'Malley M.

Am J Prev Med. 1998 Oct;15(3):246-9.

PMID:
9791644
9.

Patterns and predictors of colorectal cancer test use in the adult U.S. population.

Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ.

Cancer. 2004 May 15;100(10):2093-103.

10.

Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time.

Doubeni CA, Laiyemo AO, Young AC, Klabunde CN, Reed G, Field TS, Fletcher RH.

Ann Fam Med. 2010 Jul-Aug;8(4):299-307. doi: 10.1370/afm.1112.

11.

Trends in colorectal cancer testing among Medicare subpopulations.

Fenton JJ, Cai Y, Green P, Beckett LA, Franks P, Baldwin LM.

Am J Prev Med. 2008 Sep;35(3):194-202. doi: 10.1016/j.amepre.2008.05.029. Epub 2008 Jul 10.

PMID:
18619761
12.

Physicians' use of nonphysician healthcare providers for colorectal cancer screening.

Sansbury LB, Klabunde CN, Mysliwiec P, Brown ML.

Am J Prev Med. 2003 Oct;25(3):179-86.

PMID:
14507523
13.

Why hasn't this patient been screened for colon cancer? An Iowa Research Network study.

Levy BT, Nordin T, Sinift S, Rosenbaum M, James PA.

J Am Board Fam Med. 2007 Sep-Oct;20(5):458-68.

14.

Colorectal cancer screening among African Americans: the importance of physician recommendation.

Taylor V, Lessler D, Mertens K, Tu SP, Hart A, Chan N, Shu J, Thompson B.

J Natl Med Assoc. 2003 Sep;95(9):806-12.

15.

Longitudinal Rates of Colon Cancer Screening Use in Winnipeg, Canada: The Experience of a Universal Health-Care System with an Organized Colon Screening Program.

Decker KM, Demers AA, Nugent Z, Biswanger N, Singh H.

Am J Gastroenterol. 2015 Dec;110(12):1640-6. doi: 10.1038/ajg.2015.206. Epub 2015 Jul 14.

16.
17.

Predictors of colorectal cancer testing using the California Health Inventory Survey.

Modiri A, Makipour K, Gomez J, Friedenberg F.

World J Gastroenterol. 2013 Feb 28;19(8):1247-55. doi: 10.3748/wjg.v19.i8.1247.

18.

Trends in colorectal cancer test use among vulnerable populations in the United States.

Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1611-21. doi: 10.1158/1055-9965.EPI-11-0220. Epub 2011 Jun 8.

19.

Predictors of colorectal cancer screening participation in the United States.

Ioannou GN, Chapko MK, Dominitz JA.

Am J Gastroenterol. 2003 Sep;98(9):2082-91.

PMID:
14499792
20.

Colon cancer screening in the ambulatory setting.

Walsh JM, Posner SF, Perez-Stable EJ.

Prev Med. 2002 Sep;35(3):209-18.

PMID:
12202062

Supplemental Content

Support Center